KING OF PRUSSIA, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced that it has ...

What's next for the stock? We take a look at earnings estimates for some clues. Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for ...

NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them. The deal follows a three-year stand off ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The results nevertheless make Opdualag an alternative to Opdivo plus Yervoy (ipilimumab) – BMS' notoriously hard to tolerate CTLA4 checkpoint inhibitor – which has been approved as a ...

The transaction closed on May 30, 2025, following the approval by requisite majorities of holders of Checkpoint’s shares at a special meeting of Checkpoint’s stockholders on May 28, 2025. “We are ...